Pulmatrix, Inc. (NASDAQ:PULM), a pharmaceutical company currently valued at $27.4 million, announced on Monday that its board of directors approved an amendment to the company's bylaws, specifically ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback